• Global, Regional, and Country-specific Lifetime Risks of Stroke, 1990 and 2016

      GBD 2016 Lifetime Risk of Stroke Collaborators; Feigin, VL; Nguyen, G; Cercy, K; Johnson, CO; Alam, T; Parmar, PG; Abajobir, AA; Abate, KH; Abd-Allah, F; Abejie, AN; Abyu, GY; Ademi, Z; Agarwal, G; Ahmed, MB; Akinyemi, RO; Al-Raddadi, R; Aminde, LN; Amlie-Lefond, C; Ansari, H; Asayesh, H; Asgedom, SW; Atey, TM; Ayele, HT; Banach, M; Banerjee, A; Barac, A; Barker-Collo, SL; Bärnighausen, T; Barregard, L; Basu, S; Bedi, N; Behzadifar, M; Béjot, Y; Bennett, DA; Bensenor, IM; Berhe, DF; Boneya, DJ; Brainin, M; Campos-Nonato, IR; Caso, V; Castañeda-Orjuela, CA; Rivas, JC; Catalá-López, F; Christensen, H; Criqui, MH; Damasceno, A; Dandona, L; Dandona, R; Davletov, K; de Courten, B; deVeber, G; Dokova, K; Edessa, D; Endres, M; Faraon, EJA; Farvid, MS; Fischer, F; Foreman, K; Forouzanfar, MH; Gall, SL; Gebrehiwot, TT; Geleijnse, JM; Gillum, RF; Giroud, M; Goulart, AC; Gupta, R; Gupta, R; Hachinski, V; Hamadeh, RR; Hankey, GJ; Hareri, HA; Havmoeller, R; Hay, SI; Hegazy, MI; Hibstu, DT; James, SL; Jeemon, P; John, D; Jonas, JB; Jóźwiak, J; Kalani, R; Kandel, A; Kasaeian, A; Kengne, AP; Khader, YS; Khan, AR; Khang, Y-H; Khubchandani, J; Kim, D; Kim, YJ; Kivimaki, M; Kokubo, Y; Kolte, D; Kopec, JA; Kosen, S; Kravchenko, M; Krishnamurthi, R; Kumar, GA; Lafranconi, A; Lavados, PM; Legesse, Y; Li, Y; Liang, X; Lo, WD; Lorkowski, S; Lotufo, PA; Loy, CT; Mackay, MT; Abd El Razek, HM; Mahdavi, M; Majeed, A; Malekzadeh, R; Malta, DC; Mamun, AA; Mantovani, LG; Martins, SCO; Mate, KK; Mazidi, M; Mehata, S; Meier, T; Melaku, YA; Mendoza, W; Mensah, GA; Meretoja, A; Mezgebe, HB; Miazgowski, T; Miller, TR; Ibrahim, NM; Mohammed, S; Mokdad, AH; Moosazadeh, M; Moran, AE; Musa, KI; Negoi, RI; Nguyen, M; Nguyen, QL; Nguyen, TH; Tran, TT; Nguyen, TT; Anggraini Ningrum, DN; Norrving, B; Noubiap, JJ; O’Donnell, MJ; Olagunju, AT; Onuma, OK; Owolabi, MO; Parsaeian, M; Patton, GC; Piradov, M; Pletcher, MA; Pourmalek, F; Prakash, V; Qorbani, M; Rahman, M; Rahman, MA; Rai, RK; Ranta, A; Rawaf, D; Rawaf, S; Renzaho, AMN; Robinson, SR; Sahathevan, R; Sahebkar, A; Salomon, JA; Santalucia, P; Santos, IS; Sartorius, B; Schutte, AE; Sepanlou, SG; Shafieesabet, A; Shaikh, MA; Shamsizadeh, M; Sheth, KN; Sisay, M; Shin, M-J; Shiue, I; Silva, DAS; Sobngwi, E; Soljak, M; Sorensen, RJD; Sposato, LA; Stranges, S; Suliankatchi, RA; Tabarés-Seisdedos, R; Tanne, D; Nguyen, CT; Thakur, JS; Thrift, AG; Tirschwell, DL; Topor-Madry, R; Tran, BX; Nguyen, LT; Truelsen, T; Tsilimparis, N; Tyrovolas, S; Ukwaja, KN; Uthman, OA; Varakin, Y; Vasankari, T; Venketasubramanian, N; Vlassov, VV; Wang, W; Werdecker, A; Wolfe, CDA; Xu, G; Yano, Y; Yonemoto, N; Yu, C; Zaidi, Z; El Sayed Zaki, M; Zhou, M; Ziaeian, B; Zipkin, B; Vos, T; Naghavi, M; Murray, CJL; Roth, GA (Massachusetts Medical Society, 2018)
      BACKGROUND: The lifetime risk of stroke has been calculated in a limited number of selected populations. We sought to estimate the lifetime risk of stroke at the regional, country, and global level using data from a ...
    • Incidence of Transient Ischemic Attack in Auckland, New Zealand, in 2011 to 2012

      Barber, PA; Krishnamurthi, R; Parag, V; Anderson, NE; Ranta, A; Klifoyle, D; Wong, E; Green, G; Arroll, B; Bennett, DA; Witt, E; Rush, E; Suh, FM; Theadom, A; Rathnasabapathy, Y; Te Ao, B; Parmar, P; Feigin, V; for the ARCOS IV study group (American Heart Association, 2016)
      Background and Purpose—There have been few recent population-based studies reporting the incidence (first ever) and attack rates (incident and recurrent) of transient ischemic attack (TIA). Methods—The fourth Auckland ...
    • Methodology of the Stroke Self-management Rehabilitation Trial: An International, Multisite Pilot Trial

      Jones, KM; Bhattacharjee, R; Krishnamurthi, R; Blanton, S; Theadom, A; Barker-Collo, S; Thrift, A; Parmar, P; Maujean, A; Ranta, A; Sanya, E; Feigin, VL; on behalf of the SMART Study Group (Elsevier, 2015)
      Rationale Stroke is a major cause of long-term adult disability with many survivors living in the community relying on family members for on-going support. However, reports of inadequate understanding of rehabilitation ...
    • Plasma Cyclic Glycine Proline/IGF‐1 Ratio Predicts Clinical Outcome and Recovery in Stroke Patients

      Fan, D; Krishnamurthi, R; Harris, P; Barber, PA; Guan, J (Wiley Open Access, 2019)
      Objective: Many stroke patients make a partial recovery in function during the first 3 months, partially through promoting insulin-like growth factor-1 (IGF-1) function. A prognostic biomarker that associates with IGF-1 ...
    • Plasma cyclic glycine proline/IGF‐1 ratio predicts clinical outcome and recovery in stroke patients

      Fan, D; Krishnamurthi, R; Harris, P; Barber, PA; Guan, J (Wiley Open Access, 2019)
    • Prevalence of Muscular Dystrophies: A Systematic Literature Review

      Theadom, A; Rodrigues, M; Roxburgh, R; Balalla, S; Higgins, C; Bhattacharjee, R; Jones, K; Krishnamurthi, R; Feigin, V (Karger, 2014)
      Background: Determining the prevalence of neuromuscular disorders for the general population is important to identify the scope of burden on society and enable comparisons with other health conditions. This systematic ...